OMNIQ RECEIVES $5.0M IN PURCHASE ORDERS FOR THE SUPPLY OF HARDWARE, SOFTWARE AND SERVICES FOR ONE OF THE LARGEST US BASED FOOD AND DRUG CHAINS.
January 24, 2024 08:30 ET
|
OMNIQ Corp.
SALT LAKE CITY, Jan. 24, 2024 (GLOBE NEWSWIRE) -- OMNIQ Corp. (NASDAQ: OMQS) (“OMNIQ” or “the Company”), a provider of Artificial Intelligence (AI)-based solutions, announced today that it received...
Hoverink Biotechnologies, Inc., today announced that they have completed an application with the USPTO for KAIYADRU®. Hoverink Biotechnologies, Inc plans to develop and commercialize KAIYADRU®
November 09, 2018 18:42 ET
|
Hoverink Biotechnologies, Inc
Overview On September 26, 2018 We filed trademark applications covering: LOS ANGELES, CA, Nov. 09, 2018 (GLOBE NEWSWIRE) -- KAIYADRU® Pharmaceutical preparations, namely,...